Cargando…
Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
PURPOSE: This study examined health care utilization and costs during the first year of life for preterm and full-term infants in the US. SUBJECTS AND METHODS: Preterm (<37 weeks gestational age [GA]) and full-term infants born 2003 to 2012 without complex medical conditions were identified in th...
Autores principales: | McLaurin, Kimmie K, Wade, Sally W, Kong, Amanda M, Diakun, David, Olajide, Ifedapo R, Germano, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455110/ https://www.ncbi.nlm.nih.gov/pubmed/31040740 http://dx.doi.org/10.2147/PHMT.S182296 |
Ejemplares similares
-
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017) -
National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015
por: Krilov, Leonard R, et al.
Publicado: (2017) -
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants
por: McLaurin, K K, et al.
Publicado: (2016) -
Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018) -
The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)